Join us at TEDMED2013, where Milsal McCaull will be a part of the launch of the Genomic Think Tank, a group focused on moving from the promise and potential of genomics clinical utility to the realization of that potential.   The group examines a broad array of questions related to the technology, data output and analysis and stakeholder concerns as genomics moves from the lab to the marketplace.  Participants represented a wide array of academic, market and legal perspectives, from companies such as Affymetrix, Complete Genomics, Dell, GE, Genome Health Solutions, Illumina, Life Technologues, m-Health Technologies, Parabase Genomics, The Scripps Research Institute, Sequenom, SV Bio, tgen, UCSF, UC Irvine, SeventyK, Stanford, Smart Patients and more. 

The panel will be moderated by Theodore Sullivan, Counsel at Buchanan Ingersoll & Rooney, advising the FDA.   For more information and to apply, visit TEDMED.com.

.